| |
---|
| Detailed Price Information Link |
PLASMIDS | |
Name: | SAL |
DSM No.: | 4478 dsm-4478 dsm4478 dsm 4478 SAL |
History: | <- I.C. Gunsalus |
Mol. weight: | 85 kb |
Marker: | Salicylate degradation |
Remarks: | Transmissible plasmid; Inc P-9; encodes meta pathway enzymes for ultimate oxidation of salicylate; salicylate is used as carbon source. |
Distributed in: | Pseudomonas putida PpG2100 |
Cultivation conditions: | Medium 445, 28°C |
Literature: | 3435, 3488 |
Risk group: | 2 (classification according to German TRBA) |
Restrictions: | Act dealing with the prevention & control of infectious diseases in man (Infektionsschutzgesetz), Category A1
|
Country: | country of origin unknown |
Date of sampling: | before 16.03.1990 |
Nagoya Protocol Restrictions: | There are NO known Nagoya protocol restrictions for this strain. |
Supplied as: | Delivery form | | Organization type | | | | Profit | | Non-Profit | | | actively growing culture | | 160,- € | | 160,- € | |
Price category 1 strain. Please see price list for freight and handling charges |
| Print data sheet |